Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Andrew Louis Warshaw, M.D.

Co-Author

This page shows the publications co-authored by Andrew Warshaw and Keith Lillemoe.
Connection Strength

4.256
  1. Ductal Carcinoma Arising in a Largely Unchanged Presumed Branch-duct IPMN After 10 Years of Surveillance. Ann Surg. 2017 Dec; 266(6):e38-e40.
    View in: PubMed
    Score: 0.189
  2. Pancreatic surgery for adenocarcinoma. Curr Opin Gastroenterol. 2012 Sep; 28(5):488-93.
    View in: PubMed
    Score: 0.132
  3. Evolution of the Whipple procedure at the Massachusetts General Hospital. Surgery. 2012 Sep; 152(3 Suppl 1):S56-63.
    View in: PubMed
    Score: 0.130
  4. Pancreatic ductal adenocarcinoma: long-term survival does not equal cure. Surgery. 2012 Sep; 152(3 Suppl 1):S43-9.
    View in: PubMed
    Score: 0.130
  5. "Evolving Trends in Pancreatic Cystic Tumors: A 3-Decade Single-Center Experience with 1290 Resections". Ann Surg. 2021 Aug 04.
    View in: PubMed
    Score: 0.061
  6. Simulated Volume-Based Regionalization of Complex Procedures: Impact on Spatial Access to Care. Ann Surg. 2021 08 01; 274(2):312-318.
    View in: PubMed
    Score: 0.061
  7. Revision of Pancreatic Neck Margins Based on Intraoperative Frozen Section Analysis Is Associated With Improved Survival in Patients Undergoing Pancreatectomy for Ductal Adenocarcinoma. Ann Surg. 2021 08 01; 274(2):e134-e142.
    View in: PubMed
    Score: 0.061
  8. Influence of Klebsiella pneumoniae and quinolone treatment on prognosis in patients with pancreatic cancer. Br J Surg. 2021 06 22; 108(6):709-716.
    View in: PubMed
    Score: 0.061
  9. Pancreatic acinar cell carcinoma: A multi-center series on clinical characteristics and treatment outcomes. Pancreatology. 2021 May 15.
    View in: PubMed
    Score: 0.060
  10. Assessment of the Long-Term Impact of Pancreatoduodenectomy on Health-Related Quality of Life Using the EORTC QLQ-PAN26 Module. Ann Surg Oncol. 2021 Aug; 28(8):4216-4224.
    View in: PubMed
    Score: 0.060
  11. Transcriptomic Analysis of Laser Capture Microdissected Tumors Reveals Cancer- and Stromal-Specific Molecular Subtypes of Pancreatic Ductal Adenocarcinoma. Clin Cancer Res. 2021 Apr 15; 27(8):2314-2325.
    View in: PubMed
    Score: 0.059
  12. Tumor Microenvironment Immune Response in Pancreatic Ductal Adenocarcinoma Patients Treated With Neoadjuvant Therapy. J Natl Cancer Inst. 2021 02 01; 113(2):182-191.
    View in: PubMed
    Score: 0.059
  13. Conditional Survival in Resected Pancreatic Ductal Adenocarcinoma Patients Treated with Total Neoadjuvant Therapy. J Gastrointest Surg. 2021 Jan 26.
    View in: PubMed
    Score: 0.059
  14. Patient and Caregiver Considerations and Priorities When Selecting Hospitals for Complex Cancer Care. Ann Surg Oncol. 2021 Aug; 28(8):4183-4192.
    View in: PubMed
    Score: 0.059
  15. Influence of Klebsiella pneumoniae and quinolone treatment on prognosis in patients with pancreatic cancer. Br J Surg. 2020 Sep 30.
    View in: PubMed
    Score: 0.058
  16. Neoplastic-Stromal Cell Cross-talk Regulates Matrisome Expression in Pancreatic Cancer. Mol Cancer Res. 2020 12; 18(12):1889-1902.
    View in: PubMed
    Score: 0.057
  17. Risk of malignancy in small pancreatic cysts decreases over time. Pancreatology. 2020 Sep; 20(6):1213-1217.
    View in: PubMed
    Score: 0.057
  18. Evaluation of Pathologic Response on Overall Survival After Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma. Pancreas. 2020 08; 49(7):897-903.
    View in: PubMed
    Score: 0.057
  19. Timing But Not Patterns of Recurrence Is Different Between Node-negative and Node-positive Resected Pancreatic Cancer. Ann Surg. 2020 08; 272(2):357-365.
    View in: PubMed
    Score: 0.057
  20. A Combination of Biochemical and Pathological Parameters Improves Prediction of Postresection Survival After Preoperative Chemotherapy in Pancreatic Cancer: The PANAMA-score. Ann Surg. 2020 Jul 07.
    View in: PubMed
    Score: 0.057
  21. FOLFIRINOX Versus Gemcitabine-based Therapy for Pancreatic Ductal Adenocarcinoma: Lessons from Patient-derived Cell Lines. Anticancer Res. 2020 Jul; 40(7):3659-3667.
    View in: PubMed
    Score: 0.057
  22. Reappraising the Concept of Conditional Survival After Pancreatectomy for Ductal Adenocarcinoma: A Bi-institutional Analysis. Ann Surg. 2020 06; 271(6):1148-1155.
    View in: PubMed
    Score: 0.056
  23. An elevated CA 19-9 is associated with invasive cancer and worse survival in IPMN. Pancreatology. 2020 Jun; 20(4):729-735.
    View in: PubMed
    Score: 0.056
  24. Variation in long-term oncologic outcomes by type of cancer center accreditation: An analysis of a SEER-Medicare population with pancreatic cancer. Am J Surg. 2020 07; 220(1):29-34.
    View in: PubMed
    Score: 0.056
  25. Impact of adjuvant therapy in patients with invasive intraductal papillary mucinous neoplasms of the pancreas. Pancreatology. 2020 Jun; 20(4):722-728.
    View in: PubMed
    Score: 0.055
  26. Primary and Metastatic Pancreatic Cancer Cells Exhibit Differential Migratory Potentials. Pancreas. 2020 01; 49(1):128-134.
    View in: PubMed
    Score: 0.055
  27. Main Pancreatic Duct to Parenchymal Thickness Ratio at Preoperative Imaging is Associated with Overall Survival in Upfront Resected Pancreatic Cancer. Ann Surg Oncol. 2020 May; 27(5):1606-1612.
    View in: PubMed
    Score: 0.054
  28. Does preoperative pharmacologic prophylaxis reduce the rate of venous thromboembolism in pancreatectomy patients? HPB (Oxford). 2020 07; 22(7):1020-1024.
    View in: PubMed
    Score: 0.054
  29. Diabetes mellitus is associated with unfavorable pathologic features, increased postoperative mortality, and worse long-term survival in resected pancreatic cancer. Pancreatology. 2020 Jan; 20(1):125-131.
    View in: PubMed
    Score: 0.054
  30. Association Between Pancreatic Fistula and Long-term Survival in the Era of Neoadjuvant Chemotherapy. JAMA Surg. 2019 10 01; 154(10):943-951.
    View in: PubMed
    Score: 0.054
  31. Predictors of Resectability and Survival in Patients With Borderline and Locally Advanced Pancreatic Cancer who Underwent Neoadjuvant Treatment With FOLFIRINOX. Ann Surg. 2019 04; 269(4):733-740.
    View in: PubMed
    Score: 0.052
  32. Intraoperative Fluid Administration and Surgical Outcomes Following Pancreaticoduodenectomy: External Validation at a Tertiary Referral Center. World J Surg. 2019 Mar; 43(3):929-936.
    View in: PubMed
    Score: 0.052
  33. Role of Tumor-Associated Macrophages in the Clinical Course of Pancreatic Neuroendocrine Tumors (PanNETs). Clin Cancer Res. 2019 04 15; 25(8):2644-2655.
    View in: PubMed
    Score: 0.051
  34. Timing But Not Patterns of Recurrence Is Different Between Node-negative and Node-positive Resected Pancreatic Cancer. Ann Surg. 2019 Jan 18.
    View in: PubMed
    Score: 0.051
  35. Lower phosphate levels following pancreatectomy is associated with postoperative pancreatic fistula formation. HPB (Oxford). 2019 07; 21(7):834-840.
    View in: PubMed
    Score: 0.051
  36. Intraoperative Dexamethasone Decreases Infectious Complications After Pancreaticoduodenectomy and is Associated with Long-Term Survival in Pancreatic Cancer. Ann Surg Oncol. 2018 Dec; 25(13):4020-4026.
    View in: PubMed
    Score: 0.050
  37. Are Staging Computed Tomography (CT) Scans of the Chest Necessary in Pancreatic Adenocarcinoma? Ann Surg Oncol. 2018 Dec; 25(13):3936-3942.
    View in: PubMed
    Score: 0.050
  38. Major Complications Independently Increase Long-Term Mortality After Pancreatoduodenectomy for Cancer. J Gastrointest Surg. 2019 10; 23(10):1984-1990.
    View in: PubMed
    Score: 0.050
  39. Staging Laparoscopy Not Only Saves Patients an Incision, But May Also Help Them Live Longer. Ann Surg Oncol. 2018 Apr; 25(4):1009-1016.
    View in: PubMed
    Score: 0.048
  40. Intraductal Papillary Mucinous Neoplasm of the Pancreas in Young Patients: Tumor Biology, Clinical Features, and Survival Outcomes. J Gastrointest Surg. 2018 02; 22(2):226-234.
    View in: PubMed
    Score: 0.047
  41. Health-related Quality of Life and Functional Outcomes in 5-year Survivors After Pancreaticoduodenectomy. Ann Surg. 2017 10; 266(4):685-692.
    View in: PubMed
    Score: 0.047
  42. Is Annual Volume Enough? The Role of Experience and Specialization on Inpatient Mortality After Hepatectomy. Ann Surg. 2017 10; 266(4):603-609.
    View in: PubMed
    Score: 0.047
  43. Diabetes mellitus in intraductal papillary mucinous neoplasm of the pancreas is associated with high-grade dysplasia and invasive carcinoma. Pancreatology. 2017 Nov - Dec; 17(6):920-926.
    View in: PubMed
    Score: 0.047
  44. Tumor engraftment in patient-derived xenografts of pancreatic ductal adenocarcinoma is associated with adverse clinicopathological features and poor survival. PLoS One. 2017; 12(8):e0182855.
    View in: PubMed
    Score: 0.046
  45. Long-term Risk of Pancreatic Malignancy in Patients With Branch Duct Intraductal Papillary Mucinous Neoplasm in a Referral Center. Gastroenterology. 2017 11; 153(5):1284-1294.e1.
    View in: PubMed
    Score: 0.046
  46. Reappraisal of Staging Laparoscopy for Patients with Pancreatic Adenocarcinoma: A Contemporary Analysis of 1001 Patients. Ann Surg Oncol. 2017 Oct; 24(11):3203-3211.
    View in: PubMed
    Score: 0.046
  47. Primary lymph node gastrinoma: A single institution experience. Surgery. 2017 11; 162(5):1088-1094.
    View in: PubMed
    Score: 0.046
  48. Potential impact of a volume pledge on spatial access: A population-level analysis of patients undergoing pancreatectomy. Surgery. 2017 08; 162(2):203-210.
    View in: PubMed
    Score: 0.046
  49. Cytologic characteristics of circulating epithelioid cells in pancreatic disease. Cancer Cytopathol. 2017 May; 125(5):332-340.
    View in: PubMed
    Score: 0.045
  50. Loss of Trefoil Factor 2 From Pancreatic Duct Glands Promotes Formation of Intraductal Papillary Mucinous Neoplasms in Mice. Gastroenterology. 2016 12; 151(6):1232-1244.e10.
    View in: PubMed
    Score: 0.043
  51. Regulation of GLI Underlies a Role for BET Bromodomains in Pancreatic Cancer Growth and the Tumor Microenvironment. Clin Cancer Res. 2016 Aug 15; 22(16):4259-70.
    View in: PubMed
    Score: 0.042
  52. Phosphorylated Histone H3 (PHH3) Is a Superior Proliferation Marker for Prognosis of Pancreatic Neuroendocrine Tumors. Ann Surg Oncol. 2016 12; 23(Suppl 5):609-617.
    View in: PubMed
    Score: 0.042
  53. Intra-pancreatic Distal Bile Duct Carcinoma is Morphologically, Genetically, and Clinically Distinct from Pancreatic Ductal Adenocarcinoma. J Gastrointest Surg. 2016 05; 20(5):953-9.
    View in: PubMed
    Score: 0.042
  54. Preoperative biliary drainage does not increase major complications in pancreaticoduodenectomy: a large single center experience from the Massachusetts General Hospital. J Hepatobiliary Pancreat Sci. 2016 Mar; 23(3):181-7.
    View in: PubMed
    Score: 0.042
  55. Selective and reversible suppression of intestinal stem cell differentiation by pharmacological inhibition of BET bromodomains. Sci Rep. 2016 Feb 09; 6:20390.
    View in: PubMed
    Score: 0.042
  56. Operative Versus Nonoperative Management of Nonfunctioning Pancreatic Neuroendocrine Tumors. J Gastrointest Surg. 2016 Feb; 20(2):277-83.
    View in: PubMed
    Score: 0.041
  57. Intraductal papillary mucinous neoplasms of the pancreas with concurrent pancreatic and periampullary neoplasms. Eur J Surg Oncol. 2016 Feb; 42(2):197-204.
    View in: PubMed
    Score: 0.041
  58. Patterns of Recurrence After Resection of IPMN: Who, When, and How? Ann Surg. 2015 Dec; 262(6):1108-14.
    View in: PubMed
    Score: 0.041
  59. Health Insurance Expansion and Treatment of Pancreatic Cancer: Does Increased Access Lead to Improved Care? J Am Coll Surg. 2015 Dec; 221(6):1015-22.
    View in: PubMed
    Score: 0.041
  60. A method for fixing and paraffin embedding tissue to retain the natural fluorescence of reporter proteins. Biotechniques. 2015 Sep; 59(3):153-5.
    View in: PubMed
    Score: 0.040
  61. Early Drain Removal--The Middle Ground Between the Drain Versus No Drain Debate in Patients Undergoing Pancreaticoduodenectomy: A Prospective Validation Study. Ann Surg. 2015 Aug; 262(2):378-83.
    View in: PubMed
    Score: 0.040
  62. Acute pancreatitis in intraductal papillary mucinous neoplasms: A common predictor of malignant intestinal subtype. Surgery. 2015 Nov; 158(5):1219-25.
    View in: PubMed
    Score: 0.040
  63. Circulating Epithelial Cells in Patients with Pancreatic Lesions: Clinical and Pathologic Findings. J Am Coll Surg. 2015 Sep; 221(3):699-707.
    View in: PubMed
    Score: 0.040
  64. Effects of Comorbidities on Outcomes of Patients With Intraductal Papillary Mucinous Neoplasms. Clin Gastroenterol Hepatol. 2015 Oct; 13(10):1816-23.
    View in: PubMed
    Score: 0.040
  65. Circulating tumor cells found in patients with localized and advanced pancreatic cancer. Pancreas. 2015 May; 44(4):547-50.
    View in: PubMed
    Score: 0.040
  66. IPMN involving the main pancreatic duct: biology, epidemiology, and long-term outcomes following resection. Ann Surg. 2015 May; 261(5):976-83.
    View in: PubMed
    Score: 0.040
  67. Oncocytic-type intraductal papillary mucinous neoplasms: a unique malignant pancreatic tumor with good long-term prognosis. J Am Coll Surg. 2015 May; 220(5):839-44.
    View in: PubMed
    Score: 0.039
  68. Survival in ampullary cancer: potential role of different KRAS mutations. Surgery. 2015 Feb; 157(2):260-8.
    View in: PubMed
    Score: 0.039
  69. Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer. Ann Surg. 2015 Jan; 261(1):12-7.
    View in: PubMed
    Score: 0.039
  70. Single-stage cholecystectomy at the time of pancreatic necrosectomy is safe and prevents future biliary complications: a 20-year single institutional experience with 217 consecutive patients. J Gastrointest Surg. 2015 Jan; 19(1):32-7; discussion 37-8.
    View in: PubMed
    Score: 0.038
  71. High performing whipple patients: factors associated with short length of stay after open pancreaticoduodenectomy. J Gastrointest Surg. 2014 Oct; 18(10):1760-9.
    View in: PubMed
    Score: 0.038
  72. Not all mixed-type intraductal papillary mucinous neoplasms behave like main-duct lesions: implications of minimal involvement of the main pancreatic duct. Surgery. 2014 Sep; 156(3):611-21.
    View in: PubMed
    Score: 0.038
  73. Lymphoepithelial cysts and cystic lymphangiomas: Under-recognized benign cystic lesions of the pancreas. World J Gastrointest Surg. 2014 Jul 27; 6(7):136-41.
    View in: PubMed
    Score: 0.038
  74. The effect of antecolic versus retrocolic reconstruction on delayed gastric emptying after classic non-pylorus-preserving pancreaticoduodenectomy. Am J Surg. 2015 Jun; 209(6):1028-35.
    View in: PubMed
    Score: 0.037
  75. Understanding hospital readmissions after pancreaticoduodenectomy: can we prevent them?: a 10-year contemporary experience with 1,173 patients at the Massachusetts General Hospital. J Gastrointest Surg. 2014 Jan; 18(1):137-44; discussion 144-5.
    View in: PubMed
    Score: 0.035
  76. Updated long-term outcomes and prognostic factors for patients with unresectable locally advanced pancreatic cancer treated with intraoperative radiotherapy at the Massachusetts General Hospital, 1978 to 2010. Cancer. 2013 Dec 01; 119(23):4196-204.
    View in: PubMed
    Score: 0.035
  77. Branch duct intraductal papillary mucinous neoplasms: does cyst size change the tip of the scale? A critical analysis of the revised international consensus guidelines in a large single-institutional series. Ann Surg. 2013 Sep; 258(3):466-75.
    View in: PubMed
    Score: 0.035
  78. Low degree of formal education and musical experience predict degree of music-induced stress reduction in relatives and friends of patients: a single-center, randomized controlled trial. Ann Surg. 2013 May; 257(5):834-8.
    View in: PubMed
    Score: 0.034
  79. Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection? Ann Surg. 2013 Apr; 257(4):731-6.
    View in: PubMed
    Score: 0.034
  80. N0/N1, PNL, or LNR? The effect of lymph node number on accurate survival prediction in pancreatic ductal adenocarcinoma. J Gastrointest Surg. 2013 Feb; 17(2):257-66.
    View in: PubMed
    Score: 0.034
  81. The impact of music on metabolism. Nutrition. 2012 Nov-Dec; 28(11-12):1075-80.
    View in: PubMed
    Score: 0.033
  82. Forgotten pioneers of pancreatic surgery: beyond the favorite few. Ann Surg. 2008 Jan; 247(1):191-202.
    View in: PubMed
    Score: 0.024
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.